Galectins-1 and-3 Increase in Equine Post-traumatic Osteoarthritis.
Authors: Reesink Heidi L, Nixon Alan J, Su Jin, Liu Sherry, Sutton Ryan M, Mann Sabine, Watts Ashlee E, Peterson Ryan P
Journal: Frontiers in veterinary science
Summary
# Editorial Summary: Galectins-1 and -3 in Equine Post-traumatic Osteoarthritis Galectins are regulatory proteins involved in cell adhesion, growth and programmed cell death, with emerging evidence of their involvement in various arthritic conditions in humans; this study investigated their role in equine osteoarthritis, which remains poorly characterised in horses despite their clinical significance. Using synovial fluid samples from experimentally induced carpal osteochondral injury models (n = 9 horses total) and naturally occurring carpal OA cases (n = 57), researchers measured galectin-1 and -3 concentrations via ELISA and examined mRNA expression and immunostaining patterns in synovial membrane and cartilage tissue using RT-qPCR and histochemistry. Both galectin-1 and -3 synovial fluid concentrations elevated significantly following experimental osteochondral fragmentation, whilst cartilage galectin-1 mRNA expression correlated with OA severity in naturally occurring disease; crucially, the distribution pattern differed between healthy and damaged joints, with galectin-3 predominating in superficial zone chondrocytes of healthy cartilage but galectin-1 expression increasing markedly in chondrocyte clusters and injured tissue. These findings suggest galectins may serve as biomarkers for post-traumatic OA progression and could represent therapeutic targets, though practitioners should note that distinguishing between protective and inflammatory roles requires further investigation before clinical translation into diagnostic panels or interventions.
Read the full abstract on PubMed
Practical Takeaways
- •Galectin-1 and galectin-3 may serve as novel biomarkers in synovial fluid for diagnosing or staging post-traumatic OA in clinical carpal injuries
- •The distinct staining patterns (galectin-3 in healthy cartilage, galectin-1 in injured zones) suggest these molecules have different roles in joint health versus disease that could be exploited therapeutically
- •Future therapeutic strategies targeting galectin pathways may offer disease-modifying potential for post-traumatic OA, though further mechanistic work is needed before clinical application
Key Findings
- •Synovial fluid galectin-1 and galectin-3 concentrations increased significantly following experimental osteochondral fragmentation in carpal joints
- •Cartilage galectin-1 mRNA expression increased proportionally with OA severity in naturally occurring carpal disease (n=57)
- •Healthy articular cartilage superficial zone showed intense galectin-3 staining but minimal galectin-1, with both increasing after cartilage injury
- •Galectins-1 and -3 are baseline constituents of equine synovial fluid that are upregulated in response to post-traumatic OA